227 related articles for article (PubMed ID: 25618759)
1. A shotgun approach for the identification of platinum-protein complexes.
Moraleja I; Moreno-Gordaliza E; Esteban-Fernández D; Mena ML; Linscheid MW; Gómez-Gómez MM
Anal Bioanal Chem; 2015 Mar; 407(9):2393-403. PubMed ID: 25618759
[TBL] [Abstract][Full Text] [Related]
2. Combining TBP-based rOFFGEL-IEF with FASP and nLC-ESI-LTQ-MS/MS for the analysis of cisplatin-binding proteins in rat kidney.
Moraleja I; Moreno-Gordaliza E; Mena ML; Gómez-Gómez MM
Talanta; 2014 Mar; 120():433-42. PubMed ID: 24468393
[TBL] [Abstract][Full Text] [Related]
3. TCEP-based rSDS-PAGE AND nLC-ESI-LTQ-MS/MS for oxaliplatin metalloproteomic analysis.
Mena ML; Moreno-Gordaliza E; Gómez-Gómez MM
Talanta; 2013 Nov; 116():581-92. PubMed ID: 24148449
[TBL] [Abstract][Full Text] [Related]
4. The interaction of platinum-based drugs with native biologically relevant proteins.
Brauckmann C; Wehe CA; Kieshauer M; Lanvers-Kaminsky C; Sperling M; Karst U
Anal Bioanal Chem; 2013 Feb; 405(6):1855-64. PubMed ID: 23052861
[TBL] [Abstract][Full Text] [Related]
5. OFFGEL isoelectric focusing and polyacrylamide gel electrophoresis separation of platinum-binding proteins.
Mena ML; Moreno-Gordaliza E; Moraleja I; Cañas B; Gómez-Gómez MM
J Chromatogr A; 2011 Mar; 1218(9):1281-90. PubMed ID: 21255782
[TBL] [Abstract][Full Text] [Related]
6. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Pt-protein complexes by nHPLC-ESI-LTQ MS/MS using a gel-based bottom-up approach.
Moreno-Gordaliza E; Cañas B; Palacios MA; Gómez-Gómez MM
Talanta; 2012 Jan; 88():599-608. PubMed ID: 22265547
[TBL] [Abstract][Full Text] [Related]
8. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
[TBL] [Abstract][Full Text] [Related]
9. Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro.
Sooriyaarachchi M; Narendran A; Gailer J
Metallomics; 2011 Jan; 3(1):49-55. PubMed ID: 21135941
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of cisplatin binding sites in human serum proteins using hyphenated multidimensional liquid chromatography and ESI tandem mass spectrometry.
Will J; Wolters DA; Sheldrick WS
ChemMedChem; 2008 Nov; 3(11):1696-707. PubMed ID: 18855968
[TBL] [Abstract][Full Text] [Related]
11. Non-denaturating isoelectric focusing gel electrophoresis for uranium-protein complexes quantitative analysis with LA-ICP MS.
Xu M; Frelon S; Simon O; Lobinski R; Mounicou S
Anal Bioanal Chem; 2014 Feb; 406(4):1063-72. PubMed ID: 23665639
[TBL] [Abstract][Full Text] [Related]
12. Thiol-free reducing agents in electrophoretic separations and FASP proteolytic digestions for the analysis of metal-binding proteins.
Moraleja I; Moreno-Gordaliza E; Mena ML; Gómez-Gómez MM
MethodsX; 2014; 1():175-80. PubMed ID: 26150950
[TBL] [Abstract][Full Text] [Related]
13. High speed two-dimensional protein separation without gel by isoelectric focusing-asymmetrical flow field flow fractionation: application to urinary proteome.
Kim KH; Moon MH
J Proteome Res; 2009 Sep; 8(9):4272-8. PubMed ID: 19653698
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the bottom-up mass spectrometry proteomics approach for the characterization of Pt-binding proteins: The insulin-cisplatin case study.
Moreno-Gordaliza E; Cañas B; Palacios MA; Gómez-Gómez MM
Analyst; 2010 Jun; 135(6):1288-98. PubMed ID: 20411195
[TBL] [Abstract][Full Text] [Related]
15. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.
Mandal R; Kalke R; Li XF
Chem Res Toxicol; 2004 Oct; 17(10):1391-7. PubMed ID: 15487901
[TBL] [Abstract][Full Text] [Related]
16. Comparative protein binding, stability and degradation of satraplatin, JM118 and cisplatin in human plasma in vitro.
Bell DN; Liu JJ; Tingle MD; Rattel B; Meyer TU; McKeage MJ
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1440-6. PubMed ID: 18671714
[TBL] [Abstract][Full Text] [Related]
17. Metallomics in drug development: characterization of a liposomal cisplatin drug formulation in human plasma by CE-ICP-MS.
Nguyen TT; Østergaard J; Stürup S; Gammelgaard B
Anal Bioanal Chem; 2013 Feb; 405(6):1845-54. PubMed ID: 23052859
[TBL] [Abstract][Full Text] [Related]
18. Determination of platinum drug release and liposome stability in human plasma by CE-ICP-MS.
Nguyen TT; Ostergaard J; Stürup S; Gammelgaard B
Int J Pharm; 2013 Jun; 449(1-2):95-102. PubMed ID: 23583709
[TBL] [Abstract][Full Text] [Related]
19. Distribution study of cisplatin in rat kidney and liver cancer tissues by using liquid chromatography electrospray ionization tandem mass spectrometry.
Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
J Mass Spectrom; 2015 Jun; 50(6):844-53. PubMed ID: 26169139
[TBL] [Abstract][Full Text] [Related]
20. Kinetic study on the reactions of platinum drugs with glutathione.
Hagrman D; Goodisman J; Souid AK
J Pharmacol Exp Ther; 2004 Feb; 308(2):658-66. PubMed ID: 14610218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
